Skip to content
Screener

Charles River Laboratories CRL Deferred Compensation Arrangement With Individual Compensation Expense

Deferred Compensation Arrangement With Individual Compensation Expense at other companies

Allison Transmission Holdings logo
Allison Transmission HoldingsALSN
$250K0.0%
Mayville Engineering logo
Mayville EngineeringMEC
$4.85M+218%
The Bancorp logo
The BancorpTBBK
$75K0.0%
SouthState logo
SouthStateSSB
-$20.16M-19.1%
Lincoln Educational Services Corporation logo
Lincoln Educational Services CorporationLINC
$300K+50.0%
Range Resources logo
Range ResourcesRRC
-$1.76M-1,895%

Other financials

Income statement

See full
Revenue$1.0B-2.7%
Gross profit$349.0M-3.5%
Operating income$119.9M+19.7%
Net income-$1.5M-103%
EPS (diluted)-$0.03-103%

Balance sheet

See full
Cash & equivalents$240.6M+30.2%
Total debt$3.0B+8.1%
Total equity$2.8B-15.3%
Total assets$7.5B-0.4%

Cash flow

See full
Operating cash flow$179.7M-12.2%
CapEx$31.1M-11.9%
Free cash flow$148.6M-12.2%

Valuation

See full
Market cap$12.56B+70.1%
Enterprise value$15.36B+53.4%
P/S3.1×+1.3×

Profitability

See full
Gross margin84.7%—
Operating margin13%-2.4pp
Net margin-6%—
FCF margin9.3%-5.1pp

Returns & leverage

See full
Return on equity-7.7%—
Debt / equity1.1×+0.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense.

The source filing: Charles River Laboratories’s 10-K, filed February 18, 2026.

Filed
Feb 18, 2026, 9:21 AM EST
Fiscal year
FY2025
Accession
0001100682-26-000022

The net periodic benefit cost associated with these plans for fiscal years 2025, 2024 and 2023 totaled $3.4 million, $3.0 million and $2.8 million, respectively.

Item 8. Financial Statements and Supplementary Data

FAQ

What is Charles River Laboratories's deferred compensation arrangement with individual compensation expense?
Charles River Laboratories (CRL) reported deferred compensation arrangement with individual compensation expense of $850K in Q4 2025.
How has Charles River Laboratories's deferred compensation arrangement with individual compensation expense changed year-over-year?
Charles River Laboratories's deferred compensation arrangement with individual compensation expense increased by 13.3% year-over-year, from $750K to $850K.
What is the long-term trend for Charles River Laboratories's deferred compensation arrangement with individual compensation expense?
Over 2 years (2023 to 2025), Charles River Laboratories's deferred compensation arrangement with individual compensation expense has grown at a 10.2% compound annual growth rate (CAGR), from $2.8M to $3.4M.
What does deferred compensation arrangement with individual compensation expense mean?
Deferred Compensation Arrangement With Individual Compensation Expense as reported by Charles River Laboratories International, Inc..

Ask your AI about Charles River Laboratories's deferred compensation arrangement with individual compensation expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude